Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-21

Clinical Trial Update: Clinical Study on the Risk of Left Atrial POP Ablation and Esophageal Injury Under Ultra-High Power and Related Influencing Parameters [NA]

View source ↗

Summary

A clinical trial update describing a planned study to evaluate the risk of left atrial injury, including esophageal injury, during ultra-high power atrial fibri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Third People's Hospital of Chengdu | Conditions: Ultra-High Power Ablation,Safety of Atrial Fibrillation Ablation | NA | Status: NOT_YET_RECRUITING